Attached files
| file | filename |
|---|---|
| EX-10.16 - EX-10.16.2 FIRST AMENDMENT TO THE PURCHASE AND SALE AGREEMENT - Syneos Health, Inc. | synh-ex1016_4335.htm |
| EX-10.16 - EX-10.16.5 FIFTH AMENDMENT PURCHASE AND SALE AGREEMENT - Syneos Health, Inc. | synh-ex1016_4334.htm |
| EX-21.1 - EX-21.1 SUBSIDIARIES OF THE REGISTRANT - Syneos Health, Inc. | synh-ex211_9.htm |
| EX-32.1 - EX-32.1 SECTION 906 CEO CERTIFICATION - Syneos Health, Inc. | synh-ex321_10.htm |
| EX-32.2 - EX-32.2 SECTION 906 CFO CERTIFICATION - Syneos Health, Inc. | synh-ex322_11.htm |
| 10-K - 10-K - Syneos Health, Inc. | synh-10k_20201231.htm |
| EX-31.1 - EX-31.1 SECTION 302 CEO CERTIFICATION - Syneos Health, Inc. | synh-ex311_6.htm |
| EX-31.2 - EX-31.2 SECTION 302 CFO CERTIFICATION - Syneos Health, Inc. | synh-ex312_8.htm |
| EX-10.17 - EX-10.17.11 TENTH AMENDMENT RECEIVABLES FINANCING AGREEMENT - Syneos Health, Inc. | synh-ex1017_4336.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-225459, 333-219607, 333-212154, and 333-199960 on Forms S-8, and No. 333-228559 on Forms S-3 of our reports dated February 17, 2021, relating to the financial statements of Syneos Health, Inc. and the effectiveness of Syneos Health, Inc.’s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ Deloitte & Touche LLP
Raleigh, North Carolina
February 17, 2021